. Author manuscript; available in PMC: 2013 Mar 1.

Published in final edited form as: Brain Behav Immun. 2011 Oct 2;26(3):394–400. doi: 10.1016/j.bbi.2011.09.014

Table 3.

Adjusted ordinary least squares regression analyses predicting CRP.

Model	Variable	B	95% CI	p-value
Women EBV seropositive	EBV (log₁₀)	.01	−.21–.22	.95
	Alcohol (drinks/week)	.00	.02–.03	.76
	Smoker (1 = current)	.21	−.05–.46	.11
	Comorbidities	−.03	−.10–.05	.53
	Age (yrs)	.01	−.00–.01	.20
	BMI (kg/m²)	.03	.02–.04	.00
	Cancer stage	.06	.01–.11	.02
	Sleep	−.01	−.02–.01	.33
	Inflammation-related Meds	.04	−.14–.22	.66
	F(9, 122) = 4.96			.00
	R² = .27
Women both EBV and CMV seropositive	EBV (log₁₀)	−.13	−.40–.15	.37
	CMV (log₁₀)	.34	.04–.63	.02
	Alcohol (drinks/week)	.00	−.02–.03	.76
	Smoker (1 = current)	.26	−.08–.59	.13
	Comorbidities	.03	−.07–.13	.57
	Age (yrs)	.01	−.00–.02	.07
	BMI (kg/m²)	.03	.02–.05	.00
	Cancer stage	.05	−.01–.11	.09
	Sleep	−.01	−.02–.01	.41
	Inflammation-related Meds	−.04	−.27–.19	.72
	F(10, 67) = 5.42			.00
	R² = .45